Related Experiment Video
Updated: Jul 19, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Mitral valve periprosthetic leakage: Anatomical observations in 135 patients from a multicentre study
Giuseppe De Cicco1, Claudio Russo, Antonella Moreo
1Cardiac Surgery Unit, Civic Hospital, Brescia, Italy. giudeci@libero.it
Objective:
Prosthetic valve dysfunction after mitral valve replacement (MVR) may be caused by several factors, which often lead to repeated surgery. One of the most frequent determinants of reoperation is periprosthetic leakage (PPL). A few published reports have analysed PPL incidence and postoperative results after MVR, but no specific attention has been paid towards the potential relation between anatomical factors and PPL occurrence, particularly not bacterial-related. The aim of this study was to evaluate the location of PPL after MVR through a multicentre retrospective study.
Methods:
Between January 1985 and November 2005, 135 patients underwent reoperation at four institutions because of PPL after MVR and met the study inclusion criteria. The mitral valve annulus (MVA) was analysed in a clockwise format, indicating 12 o'clock as the mid-point of anterior annulus as viewed from the atrium.
Results:
Overall hospital mortality was 3.7% (five patients). Repair of PPL was carried out in 83 cases whereas prosthetic valve replacement was necessary in 52 cases. The total number of sectors involved in PPL was 244. PPL occurred more frequently between hour 5 and hour 6, and hour 10 and hour 11, with the risk of leakage being, 2.8 and 2.0 times higher, respectively, than in any other portion of the MVA.
Conclusions:
Our study suggests that PPL occurs more frequently at antero-lateral and postero-medial segments of MVA. This finding might be linked to unusual anatomical and functional factors of the MVA and may call for adjunctive care to these sectors of MVA when performing suture placement during MVR.
Insights
Periprosthetic leakage (PPL) after mitral valve replacement (MVR) occurs more often in specific mitral valve annulus (MVA) regions. Understanding these anatomical locations can help prevent reoperations and improve patient outcomes.
Area of Science:
- Cardiovascular Surgery
- Cardiac Surgery
- Medical Device Research
Background:
- Prosthetic valve dysfunction following mitral valve replacement (MVR) often necessitates reoperation.
- Periprosthetic leakage (PPL) is a frequent cause of reoperation after MVR.
- Limited research has explored the relationship between anatomical factors and PPL, especially concerning bacterial involvement.
Purpose of the Study:
- To investigate the specific anatomical locations of periprosthetic leakage (PPL) after mitral valve replacement (MVR).
- To identify potential anatomical correlations with PPL occurrence in patients requiring reoperation.
Main Methods:
- A multicentre retrospective study included 135 patients who underwent reoperation for PPL after MVR between 1985 and 2005.
- The mitral valve annulus (MVA) was systematically analyzed in a clockwise manner to pinpoint leakage sites.
Main Results:
- Hospital mortality was 3.7%.
- PPL occurred more frequently in the antero-lateral (hour 5-6) and postero-medial (hour 10-11) segments of the MVA.
- The risk of leakage was 2.8 times higher at hour 5-6 and 2.0 times higher at hour 10-11 compared to other MVA areas.
Conclusions:
- Periprosthetic leakage (PPL) after MVR is more prevalent in the antero-lateral and postero-medial segments of the mitral valve annulus (MVA).
- These findings suggest that specific anatomical and functional characteristics of these MVA regions may predispose to PPL.
- Targeted attention to these sectors during suture placement in MVR may help reduce the incidence of PPL.
More Related Videos
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management

